Lupin and Natco secure US FDA approval for generic Bosentan tablets for oral suspension EP News Bureau Feb 10, 2025 Natco receives first-to-file exclusivity for Bosentan Tablets for Oral Suspension, 32 mg, in the US market
Lupin receives tentative FDA approval for generic Darunavir combination tablets EP News Bureau Feb 3, 2025 It will be manufactured at Lupin’s Nagpur facility in India
